Serum N-Terminal Pro-B-Type Natriuretic Peptide Level is Negatively Associated with Vascular Reactivity Index by Digital Thermal Monitoring in Patients with Hypertension

Overview

Journal Rev Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2024 Jul 30

PMID 39076346

Authors

Chien-Hao Hsiao

Chiu-Fen Yang

Ji-Hung Wang

Bang-Gee Hsu

Affiliations

Soon will be listed here.

Abstract

Background: B-type natriuretic peptide (BNP) coordinates endothelial homeostasis and remodeling, with endothelial dysfunction associated with cardiovascular mortality in the general population without heart failure. The objective of this study was to investigate the correlation between serum N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) levels and endothelial dysfunction among patients diagnosed with hypertension.

Methods: This cross-sectional, single-center study included 90 patients with hypertension. An electrochemiluminescence immunoassay measured NT-pro-BNP levels, and a digital thermal monitoring device calculated a vascular reactivity index (VRI) as a measurement for endothelial function. In this study, VRI 1.0 denoted poor vascular reactivity, 1.0 VRI 2.0 indicated intermediate vascular reactivity, and a VRI 2.0 suggested good vascular reactivity.

Results: Out of all the hypertensive patients, eight (8.9%) displayed poor vascular reactivity (VRI 1.0), while 39 (43.3%) exhibited intermediate vascular reactivity (1.0 VRI 2.0), leaving the remaining 43 patients demonstrating good vascular reactivity. Older age ( = 0.012) and elevated serum NT-pro-BNP levels ( 0.001) were found to be associated with poorer vascular reactivity. Older age ( = -0.221, = 0.036) and log-transformed serum levels of NT-pro-BNP (log-NT-pro-BNP, = -0.505, 0.001) exhibited a negative correlation with VRI values in patients with hypertension. Following a multivariate linear regression test, serum log-NT-pro-BNP level ( = -0.505, adjusted change = 0.246, 0.001) emerged as being significantly and independently associated with VRI values among hypertensive patients.

Conclusions: In patients with hypertension, there was a negative association observed between serum log-NT-pro-BNP levels and endothelial dysfunction determined by VRI values.

References

. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021; 398(10304):957-980. PMC: 8446938. DOI: 10.1016/S0140-6736(21)01330-1. View

Dietl A, Stark K, Zimmermann M, Meisinger C, Schunkert H, Birner C . NT-proBNP Predicts Cardiovascular Death in the General Population Independent of Left Ventricular Mass and Function: Insights from a Large Population-Based Study with Long-Term Follow-Up. PLoS One. 2016; 11(10):e0164060. PMC: 5053441. DOI: 10.1371/journal.pone.0164060. View

Kasiakogias A, Agabiti Rosei E, Camafort M, Ehret G, Faconti L, Ferreira J . Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension. J Hypertens. 2021; 39(8):1522-1545. DOI: 10.1097/HJH.0000000000002910. View

James P, Oparil S, Carter B, Cushman W, Dennison-Himmelfarb C, Handler J . 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2013; 311(5):507-20. DOI: 10.1001/jama.2013.284427. View

Chen T, Lee M, Ho C, Hsu B, Tsai J . Serum Adipocyte Fatty Acid-Binding Protein Level is Negatively Associated with Vascular Reactivity Index Measured by Digital Thermal Monitoring in Kidney Transplant Patients. Metabolites. 2019; 9(8). PMC: 6724141. DOI: 10.3390/metabo9080159. View

Sarzani R, Spannella F, Giulietti F, Balietti P, Cocci G, Bordicchia M . Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk. High Blood Press Cardiovasc Prev. 2017; 24(2):115-126. PMC: 5440492. DOI: 10.1007/s40292-017-0196-1. View

Pauriah M, Khan F, Lim T, Elder D, Godfrey V, Kennedy G . B-type natriuretic peptide is an independent predictor of endothelial function in man. Clin Sci (Lond). 2012; 123(5):307-12. PMC: 3353736. DOI: 10.1042/CS20110168. View

Quarti-Trevano F, Seravalle G, Grassi G . Clinical Relevance of the Sympathetic-Vascular Interactions in Health and Disease. Biomedicines. 2021; 9(8). PMC: 8394495. DOI: 10.3390/biomedicines9081007. View

Benjamin E, Larson M, Keyes M, Mitchell G, Vasan R, Keaney Jr J . Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation. 2004; 109(5):613-9. DOI: 10.1161/01.CIR.0000112565.60887.1E. View

10.

Emdin C, Anderson S, Callender T, Conrad N, Salimi-Khorshidi G, Mohseni H . Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4.2 million adults. BMJ. 2015; 351:h4865. PMC: 4586462. DOI: 10.1136/bmj.h4865. View

11.

Folsom A, Yao L, Alonso A, Lutsey P, Missov E, Lederle F . Circulating Biomarkers and Abdominal Aortic Aneurysm Incidence: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2015; 132(7):578-85. PMC: 4543558. DOI: 10.1161/CIRCULATIONAHA.115.016537. View

12.

Linssen G, Bakker S, Voors A, Gansevoort R, Hillege H, de Jong P . N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population. Eur Heart J. 2009; 31(1):120-7. DOI: 10.1093/eurheartj/ehp420. View

13.

Gimbrone Jr M, Garcia-Cardena G . Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circ Res. 2016; 118(4):620-36. PMC: 4762052. DOI: 10.1161/CIRCRESAHA.115.306301. View

14.

Baggish A, Van Kimmenade R, Januzzi Jr J . The differential diagnosis of an elevated amino-terminal pro-B-type natriuretic peptide level. Am J Cardiol. 2008; 101(3A):43-8. DOI: 10.1016/j.amjcard.2007.11.019. View

15.

Portegies M, Kavousi M, Leening M, Bos M, van den Meiracker A, Hofman A . N-terminal pro-B-type natriuretic peptide and the risk of stroke and transient ischaemic attack: the Rotterdam Study. Eur J Neurol. 2015; 22(4):695-701. DOI: 10.1111/ene.12633. View

16.

Kruger-Genge A, Blocki A, Franke R, Jung F . Vascular Endothelial Cell Biology: An Update. Int J Mol Sci. 2019; 20(18). PMC: 6769656. DOI: 10.3390/ijms20184411. View

17.

Redfield M, Rodeheffer R, Jacobsen S, Mahoney D, Bailey K, Burnett Jr J . Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002; 40(5):976-82. DOI: 10.1016/s0735-1097(02)02059-4. View

18.

Chen Y, Lee M, Lee C, Ho G, Yin W, Chang Y . N-terminal pro-B-type natriuretic peptide is associated with arterial stiffness measured using the cardio-ankle vascular index in renal transplant recipients. J Atheroscler Thromb. 2013; 20(7):646-53. DOI: 10.5551/jat.17780. View

19.

Hsu B, Wang C, Lai Y, Tsai J . Serum Galectin-3 Level Is Positively Associated with Endothelial Dysfunction in Patients with Chronic Kidney Disease Stage 3 to 5. Toxins (Basel). 2021; 13(8). PMC: 8402460. DOI: 10.3390/toxins13080532. View

20.

Heidenreich P, Bozkurt B, Aguilar D, Allen L, Byun J, Colvin M . 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022; 145(18):e895-e1032. DOI: 10.1161/CIR.0000000000001063. View